0.7774
80.62%
0.347
After Hours:
.71
-0.0674
-8.67%
Senseonics Holdings Inc stock is traded at $0.7774, with a volume of 124.79M.
It is up +80.62% in the last 24 hours and up +152.81% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$0.4304
Open:
$0.5
24h Volume:
124.79M
Relative Volume:
13.13
Market Cap:
$462.81M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-6.9535
EPS:
-0.1118
Net Cash Flow:
$-70.51M
1W Performance:
+55.39%
1M Performance:
+152.81%
6M Performance:
+74.03%
1Y Performance:
+39.32%
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
SENS
Senseonics Holdings Inc
|
0.7774 | 462.81M | 22.39M | -60.39M | -70.51M | -0.1118 |
ABT
Abbott Laboratories
|
112.31 | 194.80B | 41.22B | 5.77B | 6.49B | 3.29 |
BSX
Boston Scientific Corp
|
94.88 | 139.84B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
365.66 | 139.40B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
80.66 | 103.43B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.42 | 43.30B | 6.60B | 4.16B | 490.10M | 6.93 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-19-23 | Initiated | Jefferies | Underperform |
Aug-19-21 | Initiated | H.C. Wainwright | Buy |
Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
Oct-23-19 | Initiated | Stifel | Buy |
Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jan-29-19 | Initiated | Piper Jaffray | Neutral |
Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
SENS stock touches 52-week high at $0.76 amid robust gains - Investing.com
Senseonics Stock Surges 42% After Hours on Preliminary Revenue Report - Yahoo Finance
Senseonics Holdings sees Q4 revenue of ~$8.3M (NYSE:SENS) - Seeking Alpha
Senseonics Holdings, Inc. Announces Business Updates - GlobeNewswire
Senseonics' Eversense CGM Doubles Patient Growth, Hits Record Shipments in Q4 2024 - StockTitan
Senseonics Holdings sees Q4 revenue of ~$8.3M - MSN
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
Here’s Why Senseonics Holdings, Inc. (NYSE:SENS) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
StockNews.com Begins Coverage on Senseonics (NYSE:SENS) - MarketBeat
Senseonics Holdings (STU:6L6) Median PS Value : €0.00 (As of Dec. 23, 2024) - GuruFocus.com
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Amendment: Director Roeder Douglas A bought $37,500 worth of shares (75,000 units at $0.50), increasing direct ownership by 5% to 1,463,087 units (SEC Form 4) - Quantisnow
Senseonics (NYSE:SENS) Now Covered by StockNews.com - MarketBeat
Senseonics director Roeder buys $135,500 in stock By Investing.com - Investing.com Australia
Senseonics director Roeder buys $135,500 in stock - Investing.com
Director Roeder Douglas A bought $135,500 worth of shares (325,000 units at $0.42), increasing direct ownership by 30% to 1,413,087 units (SEC Form 4) - Quantisnow
Senseonics CFO Frederick Sullivan purchases $47,474 in stock By Investing.com - Investing.com UK
Senseonics CFO Frederick Sullivan purchases $47,474 in stock - Investing.com India
Chief Financial Officer Sullivan Frederick T. bought $47,475 worth of shares (124,933 units at $0.38), increasing direct ownership by 5% to 2,478,844 units (SEC Form 4) - Quantisnow
Transocean Inc (RIG-N) QuotePress Release - The Globe and Mail
Senseonics president and CEO Timothy Goodnow buys $97,650 in shares By Investing.com - Investing.com Nigeria
Senseonics president and CEO Timothy Goodnow buys $97,650 in shares - Investing.com India
President and CEO Goodnow Timothy T bought $97,650 worth of shares (315,000 units at $0.31), increasing direct ownership by 3% to 11,310,355 units (SEC Form 4) - Quantisnow
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch - The Manila Times
Senseonics' Eversense 365 Launch Drives Record Patient Growth, Doubles Consumer Interest - StockTitan
Senseonics stock hits 52-week low at $0.28 amid market challenges - Investing.com
SENS (Senseonics Holdings) 3-Year Revenue Growth Rate : 21.00% (As of Sep. 2024) - GuruFocus.com
Senseonics Holdings (STU:6L6) EBITDA : €-65.02 Mil (TTM As of Sep. 2024) - GuruFocus.com
Non-Invasive Blood Glucose Monitoring Devices Market Future - openPR
Senseonics (NYSE:SENS) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
SENS (Senseonics Holdings) 3-Year FCF Growth Rate : 25.30% (As of Sep. 2024) - GuruFocus.com
GSA Capital Partners LLP Buys Shares of 334,092 Senseonics Holdings, Inc. (NYSE:SENS) - Defense World
Senseonics (NYSE:SENS) Coverage Initiated at StockNews.com - Defense World
Senseonics (NYSE:SENS) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Senseonics Holdings Expands with Innovative Diabetes Solutions - TipRanks
Senseonics Holdings (STU:6L6) Inventories, Raw Materials & Components : €0.23 Mil (As of Sep. 2024) - GuruFocus.com
Senseonics' (SENS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire
Senseonics Holdings, Inc. (AMEX:SENS) Q3 2024 Earnings Call Transcript - Insider Monkey
Senseonics Q3 2024 Earnings Preview - MSN
Earnings call: Senseonics reports Q3 results, FDA approval of Eversense 365 - Investing.com
SENS stock touches 52-week low at $0.32 amid market challenges - Investing.com India
Senseonics Holdings Inc (SENS) Q3 2024 Earnings Call Highlights: - GuruFocus.com
Senseonics Holdings Inc (SENS) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance UK
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):